CCL2 and head and neck squamous cell carcinoma: One previous study found no significant difference in mean pre-therapeutic MCP-1 serum levels in HNSCC patients compared to healthy controls (45.27 ± 16.43 pg/ml versus 60.09 ± 21.83 pg/ml) (71).